Derivation of in vivo source tracking error thresholds for TRUS-based HDR prostate brachytherapy through simulation of source positioning errors.


Journal

Brachytherapy
ISSN: 1873-1449
Titre abrégé: Brachytherapy
Pays: United States
ID NLM: 101137600

Informations de publication

Date de publication:
Historique:
received: 23 01 2019
revised: 23 04 2019
accepted: 03 05 2019
pubmed: 9 6 2019
medline: 7 3 2020
entrez: 9 6 2019
Statut: ppublish

Résumé

The purpose of this study was to simulate treatment planning source positioning errors in transrectal ultrasound-based real-time high-dose-rate prostate brachytherapy treatments and determine appropriate in vivo source tracking error thresholds. Treatment planning source positioning errors were simulated for 20 patient plans in the brachytherapy treatment planning system by manually adjusting the dwell position coordinates within selected catheters without plan reoptimization. The change in dose-volume histogram (DVH) indices was calculated as a function of the source positioning error. The magnitude of the change in the DVH indices was then used to derive appropriate in vivo source tracking error thresholds. Source positioning error thresholds to prevent potentially significant changes in prostate (target) DVH metrics ranged from 2 to 5 mm, dependent on the direction of the source positioning error, as well as the relative weight of the dwell position within the plan, and its position relative to the patient anatomy. Source positioning error thresholds to prevent potentially clinically significant changes in organ at risk DVH metrics were found to be complex and patient-dependent. In vivo source tracking error thresholds for transrectal ultrasound-based real-time high-dose-rate prostate brachytherapy were investigated via the simulation of treatment planning source positioning errors. These error thresholds were found to be dependent not only on the direction of the error, but also on the endpoint. There is still the potential for larger changes in DVH indices to occur for catheter shifts smaller than the proposed threshold levels in this study.

Identifiants

pubmed: 31175015
pii: S1538-4721(19)30017-0
doi: 10.1016/j.brachy.2019.05.001
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

711-719

Informations de copyright

Copyright © 2019 American Brachytherapy Society. All rights reserved.

Auteurs

Joel Poder (J)

Department of Radiation Oncology, St George Hospital Cancer Care Centre, Kogarah, NSW, Australia; Centre for Medical Radiation Physics, University of Wollongong, NSW, Australia. Electronic address: Joel.Poder@health.nsw.gov.au.

Mauro Carrara (M)

Medical Physics Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.

Andrew Howie (A)

Department of Radiation Oncology, St George Hospital Cancer Care Centre, Kogarah, NSW, Australia.

Dean Cutajar (D)

Centre for Medical Radiation Physics, University of Wollongong, NSW, Australia.

Joseph Bucci (J)

Department of Radiation Oncology, St George Hospital Cancer Care Centre, Kogarah, NSW, Australia.

Anatoly Rosenfeld (A)

Centre for Medical Radiation Physics, University of Wollongong, NSW, Australia. Electronic address: anatoly@uow.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH